EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Comparative study between the effect of nebulized and intravenous hypertonic saline 3% on the management of patients with acute respiratory distress syndrome: a randomized controlled trial

Mohamed E. Elfakhrany, Sabry M. Ameen, Jehan M.E. Darwish, Taysser M.A. Abdalraheem

Tanta Medical Journal · 2026-04 · 54 (2) · 191-197

DOI: 10.4103/tmj.tmj_33_25 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Tanta Medical Journal, online erschienen am 20.04.2026. Verfasst von Mohamed E. Elfakhrany und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute respiratory distress syndrome (ARDS) poses an obstacle for the medical field due to its high mortality rates.

Aim

We aimed to compare the effect of nebulized and intravenous (IV) injections of hypertonic saline (HTS) 3% on the management of ARDS patients. Patient and methods This randomized controlled study included 105 patients (aged 21–60 years, both sexes) with mild to moderate ARDS (PaO₂/FiO₂≥150). Patients were randomly assigned into three equal groups: group A (Control): standard ARDS protocol, group B: standard ARDS protocol + nebulized 3% HTS (5 ml every 8 h) with twice-daily plasma Na monitoring, group C: Standard ARDS protocol + IV 3% HTS (500 ml over 24 h), maintaining plasma Na at 145–150 mEq/l Results There was a significantly higher hypoxic index in group B and group C than in group A on days 6 and 7, with group B showing a greater increase than group C. On day 7, Murray’s score was considerably lower in group B compared with groups A and C. The need for mechanical ventilation and the length of ICU stay were substantially lower in groups B and C than in groups A. After 7 days, nevertheless, there was no substantial difference in the mortality rates of the three groups.

Conclusions

Nebulized and IV HTS 3% were convenient for patients with mild to moderate ARDS, as it improved clinical status, reduced lung injury score, the need for mechanical ventilation and increased oxygenation, and arterial oxygen saturation.

Zitieren

APA

Elfakhrany, M. E., Ameen, S. M., Darwish, J. M., & Abdalraheem, T. M. (2026). Comparative study between the effect of nebulized and intravenous hypertonic saline 3% on the management of patients with acute respiratory distress syndrome: a randomized controlled trial. Tanta Medical Journal, 54(2), 191-197. https://doi.org/10.4103/tmj.tmj_33_25

Vancouver

Elfakhrany ME, Ameen SM, Darwish JM, Abdalraheem TM. Comparative study between the effect of nebulized and intravenous hypertonic saline 3% on the management of patients with acute respiratory distress syndrome: a randomized controlled trial. Tanta Medical Journal. 2026;54(2):191-197. doi:10.4103/tmj.tmj_33_25

BibTeX
@article{Elfakhrany2026,
  author = {Elfakhrany, Mohamed E. and Ameen, Sabry M. and Darwish, Jehan M.E. and Abdalraheem, Taysser M.A.},
  title = {Comparative study between the effect of nebulized and intravenous hypertonic saline 3% on the management of patients with acute respiratory distress syndrome: a randomized controlled trial},
  journal = {Tanta Medical Journal},
  year = {2026},
  volume = {54},
  number = {2},
  pages = {191--197},
  doi = {10.4103/tmj.tmj_33_25}
}
Kostenlos starten →